Gadoteridol in multiple sclerosis patients

BREAKDOWN OF THE BLOOD-BRAIN BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE SCLEROSIS

Allan G. Kermode, Alan J. Thompson, Paul S. Tofts et al. · Brain · 1990 · 580 citations

Health Sciences, Neurological Disorder, Medicine +14

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis

D. H. Miller, Paul S. Albert, Frederik Barkhof et al. · Annals of Neurology · 1996 · 444 citations

Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history

Jonathan O. Harris, Joseph A. Frank, Nicholas J. Patronas et al. · Annals of Neurology · 1991 · 306 citations

Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy.

Gary M. Nesbit, Glenn S. Forbes, Bernd W. Scheithauer et al. · Radiology · 1991 · 272 citations

Neurological Disorder, Pathology, Brain Lesion +16

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions

Mary E. Smith, Lael A. Stone, Paul S. Albert et al. · Annals of Neurology · 1993 · 242 citations

Neurological Disorder, Clinical Neurology, Neurological Progress +20